Pilot Projects Program Core

试点项目核心计划

基本信息

项目摘要

Despite recent improvements, Oklahoma continues to have high rates of tobacco use, obesity, cancer deaths, and cardiovascular deaths, arthritis disability and an opioid abuse crisis. The mission of the OSCTR Pilot Projects Program (PPP) is to accelerate discoveries into Oklahoma's health priorities by fostering innovative and collaborative clinical and translational research (CTR) projects, leading to nationally and federally funded independent research programs. Our current pilot program has received 169 applications and funded 28 with >50% female and 37.5% of these PIs from under-represented minority populations. These pilot recipients have been immensely successful garnering a total of $17.2 M of PI-level extramural funding to these new investigators or a $7.60 ROI. To do this the PPP provides pilot project funding (Aim 1), coordinates infrastructure support and mentoring for pilot investigators (Aim 2), and identifies promising but unfunded junior investigators for additional mentoring (Aim 3). This strategy is built on the hypothesis that providing junior investigators with CTR funding, infrastructure, and mentorship will coalesce a new generation of well-trained, well-funded CTR scientists equipped to translate scientific discoveries into improved clinical care and patient well-being. In all of these functions, the PPP prioritizes research that addresses prominent health issues in Oklahoma and other IDeA states. To build on these early successes, maintain this dramatically different new trajectory for OSCTR new investigators and in response to Evaluation Core and EAC feedback, the PPP has expanded from one to three award types. CTR Pilot Awards, as previous, provide 12 months of funding for at least five novel research projects per year. To address the need for interim support while analyzing, publishing, and seeking extramural funding for pilot projects, competitive Pilot Sustainability Bridge Awards will provide 6 additional months of funding for up to 3 pilot recipients per year. Finally, to better support the unique needs of our partners, the Community-Engaged Research Exploratory Awards provide 6 months of funding for projects initiating new partnerships with non-academic institutions, such as tribal institutions, community development agencies, county health improvement organizations, health departments, and primary care providers. In addition to these OSCTR-funded awards, the PPP leverages other local funding programs when possible to provide larger or additional awards in each category. Beyond providing financial support, the PPP provides an environment that nurtures the continued success of these junior investigators. Upon funding, the Pilot Kickoff Meeting introduces awardees to the OSCTR Cores, Directors, and other awardees, and helps them critique each other's proposals. Throughout the award, investigators will receive structured mentoring (Professional Development Core) and training in scientific writing to foster career development and growth toward independence. The PPP assists current and past awardees, as well as promising but unfunded applicants, to identify additional funding sources and develop a strategy for securing independent, national funding.
尽管最近有所改善,但俄克拉荷马州的烟草使用率仍然很高,肥胖,癌症死亡, 以及心血管死亡,关节炎疾病和阿片类药物滥用危机。 OSCTR飞行员的任务 项目计划(PPP)是通过培养创新的,将发现加速进入俄克拉荷马州的健康优先事项 以及协作临床和转化研究(CTR)项目,导致全国和联邦政府资助 独立研究计划。我们当前的试点计划已收到169份申请,并资助了28个 > 50%的女性和37.5%的PI来自代表性不足的少数群体。这些飞行员​​收件人有 获得了巨大的成功,总共获得了$ 17.2 m的Pi-Level壁外资金 调查人员或7.60美元的投资回报率。为此,PPP提供试点项目资金(AIM 1),坐标 试点调查人员的基础设施支持和指导(AIM 2),并确定有希望但无资金的初级 调查人员进行额外指导(AIM 3)。该策略建立在提供初级的假设的基础上 CTR资金,基础设施和指导的调查人员将合并新一代训练有素的, 资金充足的CTR科学家,能够将科学发现转化为改善的临床护理和患者 福利。在所有这些功能中,PPP优先考虑解决研究中重大健康问题的研究 俄克拉荷马州和其他想法状态。为了建立这些早期的成功,请保持这种截然不同的新事物 OSCTR新研究人员的轨迹,并响应评估核心和EAC反馈,PPP具有 从一种奖励类型扩展到三种。以前,CTR飞行员奖提供了12个月的AT资金 每年至少五个新颖的研究项目。在分析,发布, 并寻求针对试点项目的壁外资金,竞争性的飞行员可持续发展桥将提供6个 每年最多3个试点接收者的额外资金。最后,更好地支持 我们的合作伙伴,社区参与的研究探索奖为项目提供6个月的资金 与非学术机构(例如部落机构,社区发展)建立新的伙伴关系 机构,县健康改善组织,卫生部门和初级保健提供者。在 除了这些OSCTR资助的奖项外,PPP在可能的情况下利用其他本地资助计划 在每个类别中提供更大或其他奖项。除了提供财政支持之外,PPP提供了 培育这些初级调查人员持续成功的环境。资金后,飞行员开球 会议向OSCTR核心,董事和其他获奖者介绍获奖者,并帮助他们批评 彼此的建议。在整个奖项中,调查人员将获得结构化的指导(专业人士 发展核心)和科学写作培训,以促进职业发展和成长 独立。 PPP协助当前和过去的获奖者以及有希望但没有资金的申请人 确定额外的资金来源,并制定确保独立的国家资金的战略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Heloise. ANNE Pereira其他文献

Heloise. ANNE Pereira的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Heloise. ANNE Pereira', 18)}}的其他基金

Novel Ophthalmic Product for Corneal Infections and Injuries
用于治疗角膜感染和损伤的新型眼科产品
  • 批准号:
    10156366
  • 财政年份:
    2021
  • 资助金额:
    $ 56.24万
  • 项目类别:
50th Annual Meeting of the Society for Leukocyte Biology (SLB). Leukocyte Memory: Health and Disease
白细胞生物学学会 (SLB) 第 50 届年会。
  • 批准号:
    9398529
  • 财政年份:
    2017
  • 资助金额:
    $ 56.24万
  • 项目类别:
48th Annual Meeting of the Society for Leukocyte Biology - Immunity in Health and Disease
白细胞生物学学会第 48 届年会 - 健康与疾病中的免疫
  • 批准号:
    8986501
  • 财政年份:
    2015
  • 资助金额:
    $ 56.24万
  • 项目类别:
Pilot Projects Program Core
试点项目核心计划
  • 批准号:
    10218190
  • 财政年份:
    2013
  • 资助金额:
    $ 56.24万
  • 项目类别:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
开发治疗假单胞菌感染的抗菌肽
  • 批准号:
    7324392
  • 财政年份:
    2007
  • 资助金额:
    $ 56.24万
  • 项目类别:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
开发治疗假单胞菌感染的抗菌肽
  • 批准号:
    8142110
  • 财政年份:
    2007
  • 资助金额:
    $ 56.24万
  • 项目类别:
CAP37 and ocular inflammation
CAP37 和眼部炎症
  • 批准号:
    8135325
  • 财政年份:
    2007
  • 资助金额:
    $ 56.24万
  • 项目类别:
CAP37 and ocular inflammation
CAP37 和眼部炎症
  • 批准号:
    7500044
  • 财政年份:
    2007
  • 资助金额:
    $ 56.24万
  • 项目类别:
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
开发治疗假单胞菌感染的抗菌肽
  • 批准号:
    7925577
  • 财政年份:
    2007
  • 资助金额:
    $ 56.24万
  • 项目类别:
CAP37 and ocular inflammation
CAP37 和眼部炎症
  • 批准号:
    7322473
  • 财政年份:
    2007
  • 资助金额:
    $ 56.24万
  • 项目类别:

相似国自然基金

干旱内陆河高含沙河床对季节性河流入渗的影响机制
  • 批准号:
    52379031
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
沿纬度梯度冠层结构多样性变化对森林生产力的影响
  • 批准号:
    32371610
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
开放与二元结构下的中国工业化:对增长与分配的影响机制研究
  • 批准号:
    72373005
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
基于MF和HPLC-ICP-MS监测蛋白冠形成与转化研究稀土掺杂上转换纳米颗粒对凝血平衡的影响机制
  • 批准号:
    82360655
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
高寒草灌植被冠层与根系结构对三维土壤水分动态的影响研究
  • 批准号:
    42301019
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society
下一代本土遗传学、伦理学和社会研究人员的培训和提升计划
  • 批准号:
    10841760
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
Somos Esenciales: Community Revitalization and Health through Latino Arts and Entrepreneurship
Somos Esenciales:通过拉丁裔艺术和创业精神实现社区复兴和健康
  • 批准号:
    10781761
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
Determining the Influence of Clinicodemographic, Biologic and SDOH Factors in Racial and Ethnic Disparities in the Prognosis of Alcohol-Associated Liver Disease
确定临床人口统计学、生物和 SDOH 因素对酒精相关性肝病预后中种族和民族差异的影响
  • 批准号:
    10785492
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
Addressing Structural Disparities in Autism Spectrum Disorder through Analysis of Secondary Data (ASD3)
通过二手数据分析解决自闭症谱系障碍的结构性差异 (ASD3)
  • 批准号:
    10732506
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10730133
  • 财政年份:
    2023
  • 资助金额:
    $ 56.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了